Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 109-120 of 424
Drug study icon
RecruitingNCT03794076

Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Vishwajit Nimgaonkar, MD PhD
Condition
Schizophrenia
Device study icon
RecruitingNCT06257056

Deep Brain Stimulation for Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 70 Years
Countries
United States
Sponsor
Bradley Lega
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06817980

Disorders of the Sense of Self and Physical Activity

This summary needs review. Please check the official study record and contact the research team for details.

In Strasbourg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Other study type icon
RecruitingNCT02670447

Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies

This summary needs review. Please check the official study record and contact the research team for details.

In Saint-Etienne
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 35 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Schizophrenia
Drug study icon
RecruitingNCT05052853

Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer

This summary needs review. Please check the official study record and contact the research team for details.

In Taichung
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 45 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.